Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission
Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …
Hepatitis C treatment as prevention: evidence, feasibility, and challenges
The advent of interferon-free direct-acting antiviral therapy for hepatitis C virus (HCV)
infection has heightened discussion of treatment as prevention. Rapid scale-up in many …
infection has heightened discussion of treatment as prevention. Rapid scale-up in many …
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia
Background & Aims Population-level evidence for the impact of direct-acting antiviral (DAA)
therapy on hepatitis C virus (HCV)-related disease burden is lacking. We aimed to evaluate …
therapy on hepatitis C virus (HCV)-related disease burden is lacking. We aimed to evaluate …
The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals
Background Population‐level monitoring of hepatitis C virus (HCV) infected people across
cascades of care identifies gaps in access and engagement in care and treatment. We …
cascades of care identifies gaps in access and engagement in care and treatment. We …
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Abstract Background Hepatitis C virus (HCV) infection is endemic among people who inject
drugs (PWID) globally. Despite high prevalence, treatment uptake is low, with cumulative …
drugs (PWID) globally. Despite high prevalence, treatment uptake is low, with cumulative …
The population level cascade of care for hepatitis C in British Columbia, Canada: the BC Hepatitis Testers Cohort (BC-HTC)
Background Population-level monitoring of hepatitis C virus (HCV) infected people across
the cascade of care identifies gaps in access and engagement in care and treatment. We …
the cascade of care identifies gaps in access and engagement in care and treatment. We …
[PDF][PDF] Australian recommendations for the management of hepatitis C virus infection: a consensus statement (September 2018)
Hepatitis C Virus Infection Consensus Statement … - 2018 - research.monash.edu
Chronic hepatitis C virus (HCV) infection is a major public health challenge for Australia,
affecting about 200 000 people who are at risk of progressive liver fibrosis leading to …
affecting about 200 000 people who are at risk of progressive liver fibrosis leading to …
Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia
A government‐funded interferon‐free direct‐acting antiviral (DAA) treatment programme for
chronic hepatitis C virus (HCV) infection has been available in Australia since March 2016 …
chronic hepatitis C virus (HCV) infection has been available in Australia since March 2016 …
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
Background Uptake of hepatitis C virus (HCV) testing remains inadequate globally.
Simplified point-of-care tests should enhance HCV diagnosis and elimination. We aimed to …
Simplified point-of-care tests should enhance HCV diagnosis and elimination. We aimed to …
Elimination of hepatitis C virus in Australia: laying the foundation
The development of direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV)
infection is one of the great advances in clinical medicine in recent decades. Involving …
infection is one of the great advances in clinical medicine in recent decades. Involving …